Buscar
Mostrando ítems 1-10 de 16
Dementia diagnosis in developing countries: a cross-cultural validation study.
(Elsevier Limited, 2003)
Research into dementia is needed in developing countries. Assessment of variations in disease frequency between regions might enhance our understanding of the disease, but methodological difficulties need to be addressed. ...
Packages of care for dementia in low- and middle-income countries.
(PolS Medicine, 2009)
This is the fifth in a series of articles highlighting the delivery of "packages of care" for mental health disorders in low- and middle-income countries. Packages of care are combinations of treatments aimed at improving ...
Ageing and dementia in low and middle income countries - Using research to engage with public and policy makers.
(In ternational Review of Psychiatry, 2008)
While two thirds of the 24 million people with dementia worldwide live in low and middle income countries, very little research has been conducted to support policy making in these regions. Among the non-communicable ...
Dementia severity and weight loss: a comparison across eight cohorts. the 10/66 study.
(Alzheimer's & Dementia, 2013)
We aimed to investigate the association between dementia severity and weight loss in countries with low and middle incomes, where most prevalent cases reside. Methods: Cross-sectional catchment area surveys were performed ...
Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey.
(BMC Neurology, 2009)
1) To report site-specific normative values by age, sex and educational level for four components of the 10/66 Dementia Research Group cognitive test battery; 2) to estimate the main and interactive effects of age, sex, ...
The impact of COVID19 on Mental Health in the Hispanic Caribbean Region 2020
(International Psychogeriatric, 2020)
The recent global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic will leave its shadow over mental health in our society, especially among the most vulnerable such as elderly populations and those ...
The neurovascular unit dysfunction in Alzheimer’s disease
(International Journal o f Molecular Sciences, 2021-02-16)
Alzheimer’s disease (AD) is the most common neurodegenerative disease worldwide.
Histopathologically, AD presents with two hallmarks: neurofibrillary tangles (NFTs), and aggregates
of amyloid peptide (A ) both in the ...
Insoluble vascular amyloid deposits trigger disruption of the neurovascular unit in Alzheimer’s disease brains.
(Int. J. Mol. Sci, 2021-04-01)
Alzheimer’s disease (AD) is a neurodegenerative disease, characterized histopathologically
by intra-neuronal tau-related lesions and by the accumulation of amyloid -peptide (A ) in the brain
parenchyma and around cerebral ...
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease
(Acta Neuropathologica, 2024-03)
The risk of developing Alzheimer’s disease (AD) significantly increases in individuals carrying the APOEε4 allele. Elderly
cognitively healthy individuals with APOEε4 also exist, suggesting the presence of cellular ...
The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact
(Alzheimer’s & Dementia, 2024-02)
Two of every three persons living with dementia reside in low- and middle-income
countries (LMICs). The projected increase in global dementia rates is expected to
affect LMICs disproportionately. However, the majority ...